Post-Arrival Health Screening in Karen Refugees in Australia by Paxton, Georgia A. et al.
Post-Arrival Health Screening in Karen Refugees in
Australia
Georgia A. Paxton
1*, Katrina J. Sangster
1, Ellen L. Maxwell
2, Catherine R. J. McBride
3, Ross H. Drewe
3
1Royal Children’s Hospital, Murdoch Childrens Research Institute, Melbourne, Victoria, Australia, 2Melbourne Pathology, Melbourne, Victoria, Australia, 3ISIS Primary
Care, Melbourne, Victoria, Australia
Abstract
Objective: To document the prevalence of nutritional deficiencies, infectious diseases and susceptibility to vaccine
preventable diseases in Karen refugees in Australia.
Design: Retrospective audit of pathology results.
Setting: Community based cohort in Melbourne over the period July 2006–October 2009.
Participants: 1136 Karen refugee children and adults, representing almost complete local area settlement and 48% of total
Victorian Karen humanitarian intake for the time period.
Main Outcome Measures: Prevalence of positive test results for refugee health screening, with breakdown by age group
(,6 years, 6–11 years, 12–17 years, 18 years and older).
Results: Overall prevalence figures were: anaemia 9.2%, microcytosis 19.1%, iron deficiency 13.1%, low vitamin B12 1.5%, low
folate 1.5%, abnormal thyroid function tests 4.4%, vitamin D,50 nmol/L 33.3%, hypocalcaemia 7.4%, raised alkaline
phosphatase 5.2%, abnormal liver transaminases 16.1%, hepatitis B surface antigen positive 9.7%, hepatitis B surface
antibody positive 49.5%, isolated hepatitis B core antibody positive 9.0%, hepatitis C positive 1.9%, eosinophilia 14.4%,
Schistosoma infection 7%, Strongyloides infection 20.8%, malaria 0.2%, faecal parasites 43.4%. Quantiferon-gold screening
was positive in 20.9%. No cases of syphilis or HIV were identified. Serological immunity to vaccine preventable diseases was
87.1% for measles, 95% for mumps and 66.4% for rubella; 56.9% of those tested had seroimmunity to all three.
Conclusions: Karen refugees have high rates of nutritional deficiencies and infectious diseases and may be susceptible to
vaccine preventable diseases. These data support the need for post-arrival health screening and accessible, funded catch-up
immunisation.
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Introduction
Australia accepts 13,750 refugees annually under its Human-
itarian program. Source countries vary from year to year, however
since 2006 there have been increasing numbers of refugees from
Burma (Myanmar), reflecting regional resettlement priorities.
Many of these refugees are of Karen ethnicity and have arrived
from refugee camps in Thailand situated along the Thai-Burma
border. Large numbers of Karen people have settled in outer
metropolitan Melbourne.
Karen refugees have complex medical needs and are vulnerable
to poor health for multiple reasons. These include ongoing conflict
and human rights violations, poor conditions and disruption of
health services in their countries of origin and transit, different
patterns of communicable diseases, and issues associated with
migration, settlement and accessing services in a new country.
All permanent entrants to Australia undergo a visa health
assessment approximately six months prior to departure and many
also undergo voluntary pre-departure medical screening (PDMS)
three to five days prior to travel (Table 1). A post-arrival health
assessment is also recommended, to ensure the health of the
individual, provide immunisation catch-up and to identify
conditions of public health significance [1]. Post-arrival refugee
health assessment is voluntary, and in Victoria, is performed by
General Practitioners (GPs) in primary care.
Recent Australian guidelines for refugee health screening were
developed for people from African source countries [1–3]. Data
are lacking on the prevalence of health issues for people from more
recent Humanitarian source countries, such as Burma. It is
important to ascertain health issues for new Humanitarian arrivals
in order to respond appropriately to their health care needs,
evaluate practice guidelines and provide responsive, evidence-
based health care.
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e38194Our aim was to document the prevalence of nutritional
deficiencies, infectious diseases and susceptibility to vaccine
preventable diseases in a community-based cohort of Karen
refugees in Melbourne.
Methods
The study was approved from the Human Research Ethics
Committee of the Royal Children’s Hospital (RCH), and received
a waiver of informed consent from the institution due to the
retrospective collection of de-identified data. Approval was also
obtained by the Board of Management of the Community Health
Centre (CHC) and Executive of the Pathology provider prior to
commencement, as these institutions did not have specific Ethics
committees.
A retrospective audit was performed on the pathology screening
results for a cohort of Karen refugees settling in outer metropolitan
Melbourne from July 2006–October 2009. During this period, all
new Humanitarian entrants were referred by the local settlement
support agency to a single CHC for post-arrival health screening,
within two weeks of arrival. The vast majority originated from
Mae La refugee camp on the Thai-Burma border and had
undergone full-PDMS. Refugee health assessments and investiga-
tions (Table 2) were performed by two GPs, based on Victorian
and Australian guidelines [1,2]. A single local commercial
pathology provider performed investigations. During the early
stages of the study period, screening tests were not completed
uniformly; due to pressures on service delivery with a large influx
of refugees, provider discretion in screening, and challenges with
implementing primary care refugee screening. Screening guide-
lines were applied with greater consistency after consolidating
protocols with the pathology provider in November 2007.
Participants were identified from the pathology provider
database using a combination of refugee screening identifiers
(Schistosoma serology, ordering GP and CHC location) and taking
the first test ordered of each of the pre-defined set of refugee
screening investigations. Individual pathology identification num-
bers and names were crosschecked against the electronic data
system of the CHC to verify ethnicity using naming convention
and language (Karen language), which was recorded in the
individual case notes.
Data were checked for duplicates and missing information, then
de-identified for analysis and manipulated using Microsoft Excel
(Microsoft Corporation, Redmond, Washington). Age and gender
specific reference ranges used by the pathology provider were used
to define normal results, except for vitamin D, where mild
deficiency was defined as ,50 nmol/L and moderate – severe
deficiency as levels #25 nmol/L [4,5].
Results are presented by age groups in order to appraise health
issues across the lifespan and to inform both adult and paediatric
health care. Fisher’s exact test was used to compare proportions
where appropriate (GraphPad Software Inc).
The Department of Immigration and Citizenship (DIAC)
Settlement Reporting Facility (SRF) [6] was checked for numbers
of Humanitarian entrants of Karen ethnicity settling in the Local
Government Area (LGA) over the study time period.
Results
In total 1190 people were identified from the Pathology
provider database using the combination of refugee identifiers,
1136 (95%) were Karen ethnicity (49% female), and were included
in the study. The Karen cohort ranged in age from 6 months to 87
years (Table 3). The DIAC SRF identified 1039 Karen arrivals
(49% female) to the local area over the same time period [6].
Screening results are shown in Table 4. Screening for
haematology/nutrition parameters, thyroid function, Tuberculosis
(TB), Schistosoma, Strongyloides, faecal pathogens and STIs was
performed throughout the study period. Screening for malaria was
completed on 427 consecutive Karen patients over the period July
2006–July 2007, and was then only used on a discretionary basis
for those with symptoms. Screening for seroimmunity to measles,
and mumps commenced in February 2007 (958 arrivals after this
time), screening for corrected calcium levels commenced in August
2007 (609 arrivals after this time), routine screening results for
hepatitis B, C, A and HIV were available from November 2007
(544 arrivals after this time); screening for rubella immunity in
older adolescents and adults also commenced at this time.
Table 1. Visa Medical Examination and Pre-departure Medical Screening (PDMS) [31].
Visa Medical Examination
Height and Weight All applicants
Full medical examination All applicants
Urine dipstick testing Applicants $5 years
Chest x-ray (CXR) Aged $11 years and younger if any indications of TB disease or a history of contact
with TB
Human Immunodeficiency Virus (HIV) serology All applicants aged $15 years
Syphilis serology All applicants aged $15 years
Hepatitis B virus (HBV) screening International adoptees, unaccompanied minors, pregnant women
PDMS – full assessment*
Fitness to fly assessment All applicants
RDT for malaria and treatment if positive All applicants
Albendazole dose given All applicants $6months
MMR vaccination given 9 months–30 years of age
*There is variation in the timing of the visa medical examination, and uptake of PDMS and screening may be limited, especially for children. The full PDMS is used in
Thailand (the port of departure for most of this cohort). A short form of PDMS is also used in some ports of departure, which is an assessment of ‘fitness to fly’.
doi:10.1371/journal.pone.0038194.t001
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the lifespan, but were most prevalent in children ,6 years. Where
microcytosis was present, the proportion with low ferritin was
58.7% (27/46) in those ,6 years, 2.2% (1/46) in those aged 6–11
years, 8.0% (2/25) in those aged 12–18 years and 21.3% (20/95)
in adults.
A high prevalence of vitamin D deficiency (,50 nmol/L) was
found across all age groups, particularly in adolescents (44.3%).
Males were significantly more likely to have vitamin D$50 nmol/
L compared to females in the adolescent (50/74 vs 42/92,
p=0.007) and adult age groups (250/317 vs 177/298, p,0.0001).
The proportion of people with low vitamin D levels was similar
over autumn, summer and winter (29.3–32.3%) and significantly
higher in spring compared to summer (40.3%, 85/211 vs 49/167,
p=0.03). Hypocalcaemia was common; particularly in adoles-
cents, although the proportion with an elevated ALP was similar in
all age groups (4.5–5.7%). In those with moderate to severe
vitamin D deficiency, 10.5% (4/38) had an elevated ALP,
compared to 3.9% (13/333) of those with mild deficiency and
5.5% (41/748) of those with normal vitamin D levels. No cases of
clinical rickets or fractures were identified.
An age gradient was found for the presence of hepatitis B
infection (both sAg and cAb). Positive Hepatitis B cAb was an
isolated finding (sAg negative, sAb negative) in 9.0% (49/545) of
those tested. In those who were sAg positive, hepatitis B e antigen
(eAg) was also positive in 50% (4/8) of those aged 12–17 years and
26.8% (11/41) of adults. Hepatitis B infection (sAg positive) was
found in four of the 10 adults with HCV infection, and co-
infection with hepatitis B and Schistosoma was found in 2.7% (15/
548) of those screened for both conditions. Raised liver
transaminases were common in adults; using an upper limit of
40 IU/L, 25.7% of adults (162/631) had a raised alanine
transaminase (ALT); this proportion was 56.0% (23/41) in adults
who were HBsAg positive.
Vaccination accounted for nearly all hepatitis B seroimmunity
(protective titres defined as $10 IU/L) in the youngest age group
and the majority of seroimmunity in those aged 6–11 years. In
adolescents and adults, over 80% of those with seroimmunity had
been exposed to HBV and were cAb positive/sAb positive.
There was a single case of malaria detected on blood film.
There were no cases of active TB disease, no cases of HIV (0/541;
236 aged ,18 years), no positive screening results for syphilis or
gonorrhoea, and only 2 cases of Chlamydia.
The prevalence of pathogenic faecal parasites was higher in the
younger age groups; Giardia was the most frequent pathogenic
parasite in all age groups, and was found in 22.0% of those ,6
years, 26.4% of those aged 6–11 years, 15.3% of those aged 12–17
years and 5.8% of adults. Helminth infections were found in 3.4%
(35/1027), most commonly Ascaris lumbricoides (13 cases) and
Trichuris trichiuria (13 cases). Multiple faecal pathogens were found
in 2.9% (13/1027). Overall 78.5% (803/1027) of (fresh) faecal
specimens were noted to be unformed.
Seroimmunity to vaccine preventable diseases varied. Rubella
seroimmunity (defined by titre $28 IU/L) was 84.7% (50/59) in
those aged 12–17 years and 62.3% (188/302) in adults. Of 367
people tested for seroimmunity to all three components of measles,
mumps and rubella, 56.9% (209/367) had protective antibody
titres.
Discussion
This study represents the first community-based prevalence data
in Karen refugees in Australia and the largest cohort of Karen
refugees in the Australian literature.
Table 2. Investigations.
Recommended investigations [1–3] Additional investigations*
Full blood examination (FBE) Calcium
Iron studies Phosphate
Liver function tests (LFT) Vitamin B12
25-hydroxy vitamin D (25(OH)D) Folate
Vitamin A (children) Vitamin A (all ages)
Hepatitis B serology (surface antigen (sAg), core antibody (cAb), surface antibody (sAb)) Thyroid function tests (TFT)
Hepatitis C antibodies Measles serology
HIV screening Mumps serology
Strongyloides serology Rubella serology (adolescents, adults)
Schistosoma serology Hepatitis A serology
Treponema pallidum haemagglutination (TPHA)
Malaria thick/thin films and immunochromatographic (ICT) testing
Quantiferon-goldH
Urine Chlamydia DNA
Fresh faecal specimen
*Done routinely at the Community Health Centre at the time.
doi:10.1371/journal.pone.0038194.t002
Table 3. Age and gender of Karen refugee cohort.
Age ,6 years 6–11 years 12–17 years $18 years Total
Female 61 96 92 301 550
Male 73 106 75 319 573
Not recorded -- 1 1 2 1 3
Total 134(12%) 202(18%) 168(15%) 632(55%) 1136(100%)
doi:10.1371/journal.pone.0038194.t003
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Karen refugees. Anaemia and microcytosis were common,
particularly in young children, where iron deficiency was
prominent. Haemoglobinopathies [7] and lead toxicity [8,9] are
further possible causes/contributors to microcytosis in Karen
refugee children, although testing for these conditions is not part of
current Australian screening protocols.
Vitamin D deficiency is now well described in African refugee
cohorts in Australia, and is reported in over 85% of African
children [10], and adults [11] in Melbourne. An unexpectedly
high prevalence of vitamin D deficiency was found in Karen
refugees, particularly in females, and hypocalcaemia was common.
Despite these findings, the proportion with an elevated ALP
(suggesting increased bone turnover) was relatively constant in
Table 4. Prevalence of health issues by age group.
Parameter* Age
Haematology and nutrition ,6 years 6–11 years 12–17 years 18 years + Overall
Low haemoglobin 23.1%(30/130) 11.6% (23/199) 3.0% (5/166) 7.1% (44/618) 9.2% (102/1113)
Microcytosis 36.9%(48/130) 23.6% (47/199) 15% (25/167) 15.1% (95/630) 19.1% 215/1126
Macrocytosis 0% (0/130) 0% (0/199) 0% (0/167) 0.2% (1/630) 0.1% (1/1126)
Neutropaenia 0.8% (1/130) 0% (0/199) 1.2% (2/167) 1.4% (9/630) 1.1% (12/1126)
Eosinophilia 9.3% (12/129) 9.0% (18/199) 21.0%(35/167) 15.4% (97/630) 14.4%(162/1125)
Low ferritin 30.2%(39/129) 8.0% (16/201) 10.2%(17/167) 11.9% (75/628) 13.1%(147/1125)
Low vitamin B12 1.9% (2/106) 0.7% (1/135) 0.9% (1/111) 1.7% (8/460) 1.5% (12/812)
Low folate 1.7% (2/121) 0.5% (1/193) 0.6% (1/166) 2.0% (12/614) 1.5% (16/1094)
Low vitamin A 2.6% (3/114) 3.1% (5/160) 0% (0/132) 0.4% (2/515) 1.1% (10/921)
Vitamin D,50 nmol/L 30.0%(39/130) 33.3%(67/201) 44.3%(74/167) 31.1%(195/627) 33.3%(375/1125)
Vitamin D#25 nmol/L 3.1% (4/130) 2.5% (5/201) 7.2% (12/167) 2.9% (18/627) 3.5% (39/1125)
High ALP 4.6% (6/130) 4.5% (9/201) 4.8% (8/167) 5.7% (36/631) 5.2% (59/1129)
Hypocalcaemia 7.4% (5/68) 7.8% (6/77) 17.9% (14/78) 5.0% (17/343) 7.4% (42/566)
Other
Low TSH 1.6% (2/125) 0% (0/197) 3.6% (6/168) 4.9% (30/618) 3.4% (38/1108)
High TSH 0.8% (1/125) 0% (0/197) 0.6% (1/168) 1.5% (9/618) 1.0% (11/1108)
High ALT 1.5% (2/130) 4.0% (8/201) 6.0% (10/167) 25.7%(162/631) 16.1%(182/1129)
Infectious diseases
Hepatitis B sAg positive 0% (0/78) 4.6% (4/87) 10.3% (8/78) 13.4% (41/305) 9.7% (53/548)
Hepatitis B cAb positive 6.7% (5/75) 24.1% (21/87) 53.8% (42/78) 74.8%(228/305) 54.3% (296/545)
Hepatitis C positive 0% (0/69) 0% (0/74) 0% (0/71) 3.3% (10/305) 1.9% (10/519)
Schistosoma serology positive
{ 3.0% (4/134) 5.4% (11/202) 4.8% (8/168) 9.0% (57/632) 7.0% (80/1136)
Strongyloides serology positive 7.1% (9/127) 9.3% (16/172) 19.0%(26/137) 28.1%(151/537) 20.8%(202/973)
Malaria ICT positive 0% (0/40) 2.1% (2/97) 1.4% (1/70) 0.4% (1/238) 0.9% (4/445)
Malaria film positive 0% (0/40) 1.0% (1/97) 0% (0/70) 0% (0/238) 0.2% (1/445)
Faecal specimen – any cysts/ova/parasites 39.8%(49/123) 58.0%(112/193) 49.7%(81/163) 37.2%(204/548) 43.4%(446/1027)
Faecal pathogens
{ 26.8%(33/123) 29.5%(57/136) 19.6%(32/131) 9.7%(53/495) 17.0%(175/1027)
Urine Chlamydia DNA - - 1.8% (2/109) 0% (0/530) 0.3% (2/649)
Quantiferon-goldH-positive 5.3% (1/19) 21.8% (12/55) 14.9%(20/134) 22.6%(136/602) 20.9%(169/810)
Vaccine preventable diseases
Measles IgG positive 97.6% (41/42) 87.5% (63/72) 82.5%(94/114) 87.3%(446/511) 87.1%(644/739)
Mumps IgG positive 78.6% (33/42) 94.4%(68/72) 97.4%(111/114) 95.9%(489/510) 95.0%(701/738)
Rubella IgG positive - - 84.7% (50/59) 62.3%(188/302) 66.4%(245/369)
Hepatitis B sAb positive 69.7%(53/76) 39.1% (34/87) 43.6%(34/78) 48.9%(149/305) 49.5%(270/546)
Hepatitis B cAb & sAb positive
S ¸ 1.9% (1/53) 38.2% (13/34) 85.3% (29/34) 87.2(130/149) 64.1%(173//270)
Hepatitis A IgG positive 22.7% (17/75) 83.9% (73/87) 89.6% (69/77) 98.9%(274/277) 83.9%(433/516)
*Low and high defined by reference range for age/gender. Although a proportion of the population may have results outside a reference range if it is defined according
to a normal distribution; and reference ranges will not be specific to this group; in practice, most results outside the reported reference range require at least clinical
assessment, and may require treatment, hence the results are reported using the reference ranges of the pathology provider.
{Defined by titre $1: 32.
{Faecal pathogens were any one of Giardia intestinalis, Entamoeba histolytica/dispar, Cyclospora cayetanensis, Hookworm, Trichuris trichiuria, Taenia spp, Strongyloides
stercoralis, Enterobius vermicularis, Ascaris lumbricoides.
S ¸Defined by being Hepatitis B cAb positive where sAb was detected.
doi:10.1371/journal.pone.0038194.t004
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and in the different age groups, without an increase in the
youngest and adolescent age groups, as might be expected during
periods of rapid growth. Most people in the Karen community are
Fitzpatrick skin type III–IV, do not wear covering clothing, and in
this cohort, had recently arrived from areas with high incident
sunlight exposure. There were no other obvious contributors to
low vitamin D levels; obesity or use of medications affecting
vitamin D metabolism were both extremely uncommon. Although
dietary intake of calcium was typically low, and hypocalcaemia
can drive conversion of 25-OHD to active 1,25-(OH)2D via
parathyroid hormone (PTH), a raised ALP would be expected in
response to elevated PTH and an increase in 1,25-(OH)2D. Higher
levels of 24, 25-hydroxylase (which degrades both 25-OHD and
1,25-(OH)2D) are reported in South Asians [12], which is another
possible mechanism for reduced 25-OHD levels in this group. Low
vitamin D has adverse effects on bone health, and there is an
emerging body of evidence that it is associated with other effects
on health [13]. Current Australian refugee screening protocols
were developed in response to a wave of African migration, and
include vitamin D screening based on the risk factors of this group.
Given the high prevalence of vitamin D deficiency in Karen
refugees, it is difficult to cease vitamin D screening at this point,
although it will be important to establish whether low vitamin D
remains a problem for Karen refugees after settlement, and to
monitor for adverse effects on health.
Hepatitis B virus (HBV) infection was common, with an overall
prevalence of 9.7%, and an age-related gradient, reaching a
prevalence of 13.7% in adults. These figures compare to
prevalence estimates of 0.5–0.9% for Australia [14], and 6–16%
[15–17] in African refugee cohorts in Australia. Younger children
were nearly all immune due to vaccination, likely reflecting camp
immunisation programs, whereas in adolescents and adults,
immunity generally reflected exposure to infection. There was a
relatively high number of people with isolated positive cAb
serology, which requires additional follow-up. Isolated cAb
positive may represent the window phase of acute hepatitis B, a
false positive result (more common in people from low prevalence
areas), or, more commonly in people from high prevalence areas,
immunity after previous infection with waning HBsAb, or chronic
HBV infection [18].
Hepatitis B population prevalence is classified as low (,2%),
intermediate (2–7%) and high ($8%) [19]; high prevalence is
usually associated with sAb prevalence of 60–80%. In this cohort,
although the prevalence of sAg positive was high, over half the
cohort was sAb negative, and remained susceptible to HBV. This
is important from a public health perspective, as the combination
of high disease prevalence and lower than expected seroprotection
will facilitate disease transmission. Horizontal transmission is of
particular concern within households and in young children, and is
reported in other Asian refugee cohorts after settlement [20].
Household composition is often fluid in the early stages of refugee
settlement, and many families stay in shared accommodation. In
Australia, Hepatitis B immunisation is funded during early
childhood, for sexual partners and household contacts of people
with hepatitis B, and there is a catch-up program for year seven
students that will cease in 2012. Hepatitis B vaccine is not funded
for refugees except by these criteria. It may be prudent to assume
household contact is the norm rather than the exception, and to
extend funding in order to prevent transmission within the
community.
The prevalence of malaria was low, likely due to the
epidemiology of malaria in the area of origin, and well established
local control programs. Although malaria is prevalent in the area,
with 60–190 cases of malaria reported weekly in Mae La camp
over the study period [21]; the endemicity is low, and populations
do not acquire significant protective immunity, meaning infections
are generally symptomatic (and treatment is available). This is in
contrast to African refugee cohorts (from hyper-endemic areas)
arriving in Australia prior to the introduction of pre-departure
health screening; where asymptomatic parasitaemia and waning
immunity post-migration were a significant concern [17,22].
The prevalence of STIs was low, with similar findings in studies
in Mae La camp [23] and Karen refugees in the United States [8].
The low rates in Mae La camp have been attributed to geographic
isolation, religious faith, and camp governance, with defined
consequences for pregnancy or pre-marital sexual relations
(including forced marriage and restricting school access) [23].
Schistosoma infection has not been reported previously in Burma
[24]. The prevalence of Strongyloides infection was higher than the
prevalence seen in African refugees in Australia [15,25,26].
Pathogenic faecal parasites were more common in the younger
age groups, and Giardia intestinalis was common in all age groups,
despite pre-departure Albendazole, which has also been observed
in other refugee cohorts [27].
One of the most important findings of this study was inadequate
immunity to vaccine-preventable diseases, supporting the need for
targeted and accessible immunisation in the early stages of
settlement. The prevalence of serological immunity to rubella
was low, despite PDMS immunisation with MMR vaccine,
although no data were available on the timing of vaccination
compared to the timing of health screening. Susceptibility to
rubella and increased incidence of congenital rubella syndrome
have previously been reported in South Asian cohorts [28], and
this represents an important target for catch-up immunisation.
Serology to detect existing immunity to vaccine-preventable
diseases is not recommended in Australian refugee guidelines
(except hepatitis B) [2], although serology for rubella immunity
should be considered for women of childbearing age. This study
highlights some of the issues with vaccination serology. Although
the prevalence of seroimmunity to measles and mumps was
relatively high, nearly half of those tested for all three vaccine
components remained susceptible to at least one, and combination
MMR vaccine is the only option available for catch-up. Similar
issues occur for any combination vaccine. Almost all adults had
seroimmunity to hepatitis A, suggesting routine screening is
unnecessary, although targeted screening in those with liver
pathology due to other causes such as hepatitis B or C is still
recommended.
A coincidence of time and settlement patterns allowed the
collection of these data in a community sample of Karen refugees,
who currently comprise over one quarter of Australia’s current
offshore Humanitarian program intake. Only one other Australian
study provides information on health issues in Burmese refugees
[29], although this is a cohort of 156 adults referred to a specialist
refugee clinic after initial health screening, representing significant
referral bias. Three other studies report on smaller cohorts (31–
113 people) of refugees from a mixture of Asian source countries,
without breakdown by country of origin [17,26,30]. In the
international literature, only two studies are identified on the
prevalence of health issues in refugees from Burma, a small study
from Canada [7] and a larger Karen cohort from Minnesota [8].
In the cohort of 1728 Karen from Minnesota, limited data are
reported, although available prevalence figures are similar,
including hepatitis B sAg (10%), pathogenic intestinal parasites
(15%), and no sexually transmitted infections (STI) in a smaller
cohort of 170 adult patients. The current study expands this
literature and provides an overview of health issues affecting
Post-Arrival Health Screening in Karen Refugees
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clinicians working in refugee health. The findings support using
most tests included in current Australian refugee protocols for
screening in Karen refugees, with the exception of malaria and
STI testing, where targeted screening is not clinically unreason-
able.
Limitations of this study include its retrospective nature,
incomplete screening leading to selection bias, and possible
ascertainment bias. The figures in this study reflect real life
practice, and the difficulty in ordering and obtaining multiple test
specimens in primary care in a complex patient group. Screening
tests were not applied to all patients in a systematic manner.
Protocols and testing arrangements varied over time, leading to an
apparent reduction in coverage, although tests were applied to
consecutive primary care arrivals. There is also the potential for
ascertainment bias arising from the use of Schistosoma serology as an
identifier (refugees not having this screening test would be missed),
however this test was part of refugee health screening throughout
the study period. Further, clinic attendance was voluntary,
however the unusual situation of a single streamlined referral
pathway to a single local CHC, with a mandated referral process,
and the high attendance and follow-up seen in this cohort, led to
high rates of screening uptake. The number of Karen refugees
who underwent screening (1136) was slightly higher than the
number settling in the local Government area over the study
period (1039) [6]. This discrepancy most likely represents
secondary migration, but these figures suggest that this study is
likely to have captured the vast majority of new Karen refugee
arrivals to the area.
Finally, it is important to note, these data are cross-sectional and
do not provide information on the longer term health issues in this
group, or health issues arising as a result of settlement. Initial
refugee health screening is essentially a form of preventative health
care to prevent complications from parasite infections, provide
treatment for latent tuberculosis infection and detect hepatitis for
monitoring and treatment if necessary. There is limited longitu-
dinal information on the health of refugee cohorts in Australia. In
the CHC where this study was located, obesity and type 2
Diabetes Mellitus are emerging health issues in the years after
settlement.
Priorities for Australian refugee health care in the future include
the need for more rapidly responsive epidemiology for new
cohorts, but also developing systems to monitor longitudinal
outcomes, and providing an approach to preventive health care in
the initial refugee health assessment that extends beyond infectious
diseases.
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